Down-Regulation of miR-129-5p Inhibits Growth and Induces Apoptosis in Laryngeal Squamous Cell Carcinoma by Targeting APC

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Li, MingHua ^a   Tian, LinLi ^a   Wang, Lin ^a   Yao, HongChao ^a   Zhang, JiaRui ^a   Lu, JianGuang ^a   Sun, YaNan ^a   Gao, Xu ^b   Xiao, Hui ^a   Liu, Ming ^a  

^a THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; APC PROTEIN; CYCLIN D1; LENTIVIRUS VECTOR; MICRORNA; MICRORNA 129 5P; MYC PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN; MIRN129 MICRORNA, HUMAN;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CLASSIFICATION; CANCER GROWTH; CANCER INHIBITION; CANCER STAGING; CARCINOGENESIS; CELL CYCLE ARREST; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; DRUG TARGETING; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; LARYNGECTOMY; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MALE; MOUSE; NONHUMAN; ONCOGENE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; SQUAMOUS CELL CARCINOMA; TUMOR XENOGRAFT; UPREGULATION; WNT SIGNALING PATHWAY; ANIMAL; BAGG ALBINO MOUSE; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; LARYNX TUMOR; METABOLISM;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ANIMALS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; LARYNGEAL NEOPLASMS; MICE; MICE, INBRED BALB C; MICRORNAS; OLIGONUCLEOTIDES, ANTISENSE;

EID: 84886053455     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077829     Document Type: Article

References (36)

1. Mirisola V, Mora R, Esposito AI, Guastini L, Tabacchiera F, et al. (2011) A prognostic multigene classifier for squamous cell carcinomas of the larynx. Cancer Lett 307: 37-46.
2. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
3. Ambros V, (2004) The functions of animal microRNAs. Nature 431: 350-355.
4. Ebert MS, Sharp PA, (2012) Roles for microRNAs in conferring robustness to biological processes. Cell 149: 515-524.
5. Garzon R, Calin GA, Croce CM, (2009) MicroRNAs in cancer. Annu Rev Med 60: 167-179.
6. Lee YS, Dutta A, (2009) MicroRNAs in cancer. Annu Rev Pathol 4: 199-227.
7. Ren J, Zhu D, Liu M, Sun Y, Tian L, (2010) Downregulation of miR-21 modulates Ras expression to promote apoptosis and suppress invasion of Laryngeal squamous cell carcinoma. Eur J Cancer 46: 3409-3416.
8. Zhang T, Liu M, Wang C, Lin C, Sun Y, et al. (2011) Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression. Anticancer Res 31: 3859-3863.
9. Dreher A, Rossing M, Kaczkowski B, Andersen DK, Larsen TJ, et al. (2011) Differential expression of cellular microRNAs in HPV 11,-16, and-45 transfected cells. Biochem Biophys Res Commun 412: 20-25.
10. Wang X, Tang S, Le SY, Lu R, Rader JS, et al. (2008) Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 3: e2557.
11. Ogawa R, Ishiguro H, Kuwabara Y, Kimura M, Mitsui A, et al. (2009) Expression profiling of micro-RNAs in human esophageal squamous cell carcinoma using RT-PCR. Med Mol Morphol 42: 102-109.
12. Zhao JJ, Yang J, Lin J, Yao N, Zhu Y, et al. (2009) Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis. Childs Nerv Syst 25: 13-20.
13. Dyrskjot L, Ostenfeld MS, Bramsen JB, Silahtaroglu AN, Lamy P, et al. (2009) Genomic profiling microRNAs in bladder cancer:miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res 69: 4851-4860.
14. Shen R, Pan S, Qi S, Lin X, Cheng S, (2010) Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 in gastric cancer. Biochem Biophys Res Commun 394: 1047-1052.
15. Birks DK, Barton VN, Donson AM, Handler MH, Vibhakar R, et al. (2011) Survey of MicroRNA expression in pediatric brain tumors. Pediatr Blood Cancer 56: 211-216.
16. Liu Y, Hei Y, Shu Q, Dong J, Gao Y, et al. (2012) VCP/p97, down-regulated by microRNA-129-5p, could regulate the progression of hepatocellular carcinoma. PLoS One 7: e35800.
17. Chiang Y, Song Y, Wang Z, Chen Y, Yue Z, et al. (2011) Aberrant Expression of miR-203 and Its Clinical Significance in Gastric and Colorectal Cancers. J Gastrointest Surg 15: 63-70.
18. Chen X, Hu H, Guan X, Xiong G, Wang Y, et al. (2012) CpG island methylation status of miRNAs in esophageal squamous cell carcinoma. Int J Cancer 130: 1607-1613.
19. Huang YW, Liu JC, Deatherage DE, Luo J, Mutch DG, et al. (2009) Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrial cancer. Cancer Res 69: 9038-9046.
20. Bandres E, Agirre X, Bitarte N, Ramirez N, Zarate R, et al. (2009) Epigenetic regulation of microRNA expression in colorectal cancer. Int J Cancer 125: 2737-2743.
21. Huang ZM, Yang J, Shen XY, Zhang XY, Meng FS, et al. (2009) MicroRNA expression profile in non-cancerous colonic tissue associated with lymph node metastasis of colon cancer. J Dig Dis 10: 188-194.
22. Wu J, Qian J, Li C, Kwok L, Cheng F, et al. (2010) miR-129 regulates cell proliferation by downregulating Cdk6 expression. Cell Cycle 9: 1809-1818.
23. Mulholland DJ, Dedhar S, Coetzee GA, Nelson CC, (2005) Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know? Endocr Rev 26: 898-915.
24. Katoh M, Katoh M, (2007) Wnt signaling pathway and stem cell signaling network. Clin Cancer Res. 13: 4042-4045.
25. Kielman MF, Rindapaa M, Gaspar C, van Poppel N, Breukel C, et al. (2002) Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signalling. Nat Genet. 32: 594-605.
26. Ito K, Lim AC, Salto-Tellez M, Motoda L, Osato M, et al. (2008) RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis. Cancer Cell 14: 226-237.
27. Colnot S, Decaens T, Niwa-Kawakita M, Godard C, Hamard G, et al. (2004) Liver-targeted disruption of APC in mice activates beta-catenin signaling and leads to hepatocellular carcinomas. Proc Natl Acad Sci U S A 101: 17216-17221.
28. Scholer-Dahirel A, Schlabach MR, Loo A, Bagdasarian L, Meyer R, et al. (2011) Maintenance of adenomatous polyposis coli (APC)-mutant colorectal cancer is dependent on Wnt/beta-catenin signaling. Proc Natl Acad Sci U S A 108: 17135-17140.
29. Mukherjee N, Bhattacharya N, Alam N, Roy A, Roychoudhury S, et al. (2012) Subtype-specific alterations of the Wnt signaling pathway in breast cancer. clinical and prognostic significance, Cancer Sci 103: 210-220.
30. Verras M, Sun Z, (2006) Roles and regulation of Wnt signaling and beta-catenin in prostate cancer. Cancer Lett 237: 22-32.
31. Guillen-Ahlers H, (2008) Wnt signaling in renal cancer. Curr Drug Targets 9: 591-600.
32. Ebert MP, Yu J, Hoffmann J, Rocco A, Rocken C, et al. (2003) Loss of beta-catenin expression in metastatic gastric cancer. J Clin Oncol 21: 1708-1714.
33. Tsuchiya R, Yamamoto G, Nagoshi Y, Aida T, Irie T, et al. (2004) Expression of adenomatous polyposis coli (APC) in tumorigenesis of human oral squamous cell carcinoma. Oral Oncol 40: 932-940.
34. Luscher B, Vervoorts J, (2012) Regulation of gene transcription by the oncoprotein MYC. Gene 494: 145-160.
35. Dang CV, (2012) MYC on the path to cancer. Cell 149: 22-35.
36. Musgrove EA, Caldon CE, Barraclough J, Stone A, Sutherland RL, (2011) Cyclin D as a therapeutic target in cancer. Nat Rev Cancer 11: 558-572.